"Painless Play To Fatten Up Your Portfolio - Buy Arena"
New Seeking Alpha Article:
As I stated above, I consider any bio play speculative due to the constraints of the industry, however in weighing that risk, I am convinced that Arena is the best play in the bio space right now. I recommend the company as a buy and attribute that to several factors. First, management appears to do a good job controlling costs and cash burn which is the foundation for any development company. The have a spectacular research platform and one FDA approval under their belt already. The successful launch of BELVIQ will send the company's financials into positive territory and give them the resources needed for future development. Not only could BELVIQ make Arena profitable, but it could nearly double the valuation of the company currently at $1.8 billion.
Bump!! In case anyone has missed the article, at least needs to catch this much of it.
The article itself is unbiased, accurate, and very positive. A refreshing breath of fresh air among all the bull being generated. I feel articles like this will become much more common as events and the "truth" unfold in the coming days and weeks.